Didactics-Highlights of IGCS 2021 Annual Meeting_Wesley Burkett

Highlights of IGCS 2021 Annual Meeting_Wesley Burkett_Nov 2021.mp4

Video Transcription

Video Summary

In this video, Dr. Wesley Burkett discusses three different oral abstracts presented at the recent meeting. The first abstract focuses on a phase three trial comparing SNFMAP to chemotherapy in recurrent and metastatic cervical cancer. The trial showed that SNFMAP provided a statistically significant and clinically meaningful survival benefit in patients with squamous cell carcinoma. It also demonstrated benefits in overall survival and response rates for the overall population and the adenocarcinoma population. The second abstract discusses the results of the Outback trial, which studied the use of adjuvant chemotherapy in locally advanced cervical cancer. The trial showed no difference in overall survival or progression-free survival between the adjuvant chemotherapy and standard chemo-radiotherapy. The third abstract looks at MIRV in combination with bevacizumab in ovarian cancer. The combination showed promising activity in patients with high folate receptor alpha expression, regardless of platinum status. Overall, these studies provide insights into potential treatment options and highlight the need for further research in these areas.

Keywords

Dr. Wesley Burkett

oral abstracts

SNFMAP

cervical cancer

chemotherapy

ovarian cancer